Medical Condition News

RSS

COPD exacerbations accelerate lung decline

In patients with chronic obstructive pulmonary disease (COPD), exacerbations accelerated lung function loss, according to a new study presented at the ATS 2016 International Conference. The effect was particularly prominent in those with mild disease.

17 May 2016

Exercise plays significant role in combating obesity

Two factors—metabolism and gut microbes - have been credited by researchers as key players in the fight against obesity.

17 May 2016

Novel therapeutic approach to treat leukaemia patients

Cancer cells have an abnormal cell division and survival machinery - they grow faster than they die. For their permanent development, they produce an excess of growth factors and nutrients and block the body's own safety mechanisms.

17 May 2016

Researchers explore ways to design changes in living environment for older adults with dementia

As the population ages and demography changes, the UK is facing an unprecedented challenge of how to care for and support its older people.

17 May 2016

Exposing headache sufferers to pure-wavelength green light can lessen severity of migraines

Most migraine and post-traumatic headache sufferers find their headaches get worse in light, leading them to quit their most fundamental daily tasks and seek the comfort of darkness.

17 May 2016

Study shows half of smokers experience respiratory symptoms similar to COPD

A new study in the New England Journal of Medicine finds that smokers, who wouldn't typically be diagnosed with chronic obstructive pulmonary disease, or COPD, are still showing symptoms consistent with the diagnosis.

17 May 2016

McGill researchers discover role of folliculin protein in regulating activity of fat cells

Researchers have uncovered a new molecular pathway for stimulating the body to burn fat - a discovery that could help fight obesity, diabetes and cardiovascular disease.

17 May 2016

Phase 2 results of AbbVie’s venetoclax in patients with R/R CLL with 17p deletion published in The Lancet Oncology

AbbVie, a global biopharmaceutical company, today announced The Lancet Oncology published results from the Phase 2, single arm, open label trial studying venetoclax in patients with relapsed/refractory (R/R) chronic lymphocytic leukaemia (CLL) with 17p deletion.

17 May 2016

Magic mushroom compound may offer potential new way for antidepressant research

Psilocybin – a hallucinogenic compound derived from magic mushrooms – may offer a possible new avenue for antidepressant research, according to a new study published in The Lancet Psychiatry today.

17 May 2016

Studies show how speaking French could significantly reduce symptoms of Benign Essential Blepharospasm

A fascinating new study published in the latest edition of Movements Disorders (Vol.00 No.00, 2016) presents two patient case studies that demonstrate how speaking French as a second language can significantly reduce the symptoms of a life-limiting eye condition, Benign Essential Blepharospasm (BEB).

17 May 2016

New study links altered purine metabolism to major depressive disorder

People suffering from major depressive disorder may have altered purine metabolism, according to a new study from the University of Eastern Finland and Kuopio University Hospital.

17 May 2016

Could worm infection counter IBD? An interview with Dr Loke and Dr Cadwell

The hygiene hypothesis refers to the idea that decreased exposure to certain infectious agents (because of better hygiene) is the reason why we have seen an increase in inflammatory diseases in the developed world.

17 May 2016

Diets rich in fruits and vegetables can help prevent chronic inflammation

A new study by the University of Liverpool's Institute of Ageing and Chronic Disease has identified food stuffs that can help prevent chronic inflammation that contributes to many leading causes of death.

17 May 2016

Lightpoint Medical signs exclusive global license agreement with UA for Beta Emission Tomography

Lightpoint Medical, a clinical-stage medical device company developing advanced imaging technologies for intraoperative cancer detection, announced today that the company has signed an exclusive global license agreement for a molecular imaging technology called Beta Emission Tomography, developed by Professor Harrison Barrett, Regents Professor of Radiology and Optical Science, with his student Yijun Ding and colleague Dr. Luca Caucci at the University of Arizona Center for Gamma Ray Imaging.

17 May 2016

Medical Condition News

COPD exacerbations accelerate lung decline

Exercise plays significant role in combating obesity

Novel therapeutic approach to treat leukaemia patients

Researchers explore ways to design changes in living environment for older adults with dementia

Exposing headache sufferers to pure-wavelength green light can lessen severity of migraines

Study shows half of smokers experience respiratory symptoms similar to COPD

McGill researchers discover role of folliculin protein in regulating activity of fat cells

Phase 2 results of AbbVie’s venetoclax in patients with R/R CLL with 17p deletion published in The Lancet Oncology

Magic mushroom compound may offer potential new way for antidepressant research

Studies show how speaking French could significantly reduce symptoms of Benign Essential Blepharospasm

New study links altered purine metabolism to major depressive disorder

Could worm infection counter IBD? An interview with Dr Loke and Dr Cadwell

Diets rich in fruits and vegetables can help prevent chronic inflammation

Lightpoint Medical signs exclusive global license agreement with UA for Beta Emission Tomography

Philips to showcase advanced cardiology solutions at EuroPCR 2016 Congress

Children, youth may face prolonged difficulty in cognitive-motor integration after concussion

Study shows inhibition of SHP-2 enzyme can diminish lupus symptoms

Fitness may preserve lung function as we age

Severe obstructive sleep apnea may increase likelihood of cognitive deficits in children

Antipsychotic drug users may twice as likely to experience heart attack than non-users

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

A new method to measure intracellular water in biological systems

Latest News